Abeona Therapeutics (NASDAQ: ABEO) reported Q2 EPS of ($0.20), $0.04 worse than the analyst estimate of ($0.16). Revenue for the quarter came in at $214 thousand versus the consensus estimate of $240 thousand.

For earnings history and earnings-related data on Abeona Therapeutics (ABEO) click here.